Section Arrow
SPRC.NASDAQ
- SciSparc Ltd
(Financial Status)
Quotes are at least 15-min delayed:2025/07/20 19:00 EDT
Regular Hours
Last
 7.54
-0.5 (-6.22%)
Day High 
8.3343 
Prev. Close
8.04 
1-M High
8.5 
Volume 
62.18K 
Bid
7.59
Ask
8.5
Day Low
7.37 
Open
8.05 
1-M Low
6.09 
Market Cap 
4.30M 
Currency USD 
P/E
%Yield -- 
10-SMA 7.08 
20-SMA 6.77 
50-SMA 6.7 
52-W High 37.59 
52-W Low 4.137 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-22.65/--
Enterprise Value
4.31M
Balance Sheet
Book Value Per Share
15.25
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
1.31M
Operating Revenue Per Share
6.21
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
TELOTelomir Pharmaceuticals2.28+1.07+88.43%-- 
SRPTSarepta Therapeutics14.075-7.895-35.94%15.76PE
NCNANuCana plc0.0477+0.0009+1.92%-- 
RXRXRecursion Pharmaceuticals5.84+0.32+5.80%-- 
MEIPMEI Pharma5.92+1.42+31.56%1.09PE
Quotes are at least 15-min delayed:2025/07/20 19:00 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
SciSparc Ltd is a specialty clinical stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.